ClinicalTrials.Veeva

Menu

Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy (CARDIAC-OAT)

F

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Status

Enrolling

Conditions

Preeclampsia

Study type

Observational

Funder types

Other

Identifiers

NCT06858345
CARDIAC-OAT

Details and patient eligibility

About

The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.

Enrollment

50 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age greater than or equal to 18 years
  • Women with singleton and twin pregnancies complicated by hypertensive states of pregnancy.

Exclusion criteria

  • Minors under 18 years of age.
  • Women with mental disabilities.
  • Major congenital fetal anomaly.

Trial design

50 participants in 1 patient group

• Duration of gestation in pregnancy complicated by hypertensive state of pregnancy with antihyperte
Description:
• Duration of gestation in pregnancy complicated by hypertensive state of pregnancy with antihypertensive therapy guided by hemodynamic phenotypes

Trial contacts and locations

1

Loading...

Central trial contact

Catalina de Paco Matallana, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems